triamcinolone acetonide

Summary

Summary: An esterified form of TRIAMCINOLONE. It is an anti-inflammatory glucocorticoid used topically in the treatment of various skin disorders. Intralesional, intramuscular, and intra-articular injections are also administered under certain conditions.

Top Publications

  1. pmc Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema
    Michael J Elman
    Elman Retina Group, PA, Baltimore, Maryland, USA
    Ophthalmology 118:609-14. 2011
  2. ncbi Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion
    Xiaoyan Ding
    State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat Sen University, Guangzhou, China
    Retina 31:838-45. 2011
  3. ncbi PAMAM-triamcinolone acetonide conjugate as a nucleus-targeting gene carrier for enhanced transfer activity
    Kun Ma
    Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, PR China
    Biomaterials 30:6109-18. 2009
  4. ncbi Macular grid photocoagulation after intravitreal triamcinolone acetonide for diffuse diabetic macular edema
    Se Woong Kang
    Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 135 710, Korea
    Arch Ophthalmol 124:653-8. 2006
  5. pmc Intravitreal triamcinolone acetonide inhibits breakdown of the blood-retinal barrier through differential regulation of VEGF-A and its receptors in early diabetic rat retinas
    Xinyuan Zhang
    Save Sight Institute, Department of Clinical Ophthalmology, University of Sydney, Sydney, Australia
    Diabetes 57:1026-33. 2008
  6. ncbi Randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus macular photocoagulation in diabetic macular edema
    Masoud Soheilian
    Ophthalmology Department, Labbafinejad Medical Center, Shaheed Beheshti Medical University, Tehran, Iran
    Ophthalmology 116:1142-50. 2009
  7. ncbi Cytomegalovirus retinitis after intravitreous triamcinolone in an immunocompetent patient
    Michael A Saidel
    Francis I Proctor Foundation, University of California at San Francisco, 95 Kirkham Street, San Francisco, CA 94143, USA
    Am J Ophthalmol 140:1141-3. 2005
  8. ncbi Cytomegalovirus retinitis following intravitreal injection of triamcinolone: report of two cases
    Marie Noelle Delyfer
    Vitreo Retinal Unit, Department of Ophthalmology, Bordeaux Univeristy Hospital, Bordeaux, France
    Acta Ophthalmol Scand 85:681-3. 2007
  9. ncbi Triamcinolone acetonide in silicone-filled eyes as adjunctive treatment for proliferative vitreoretinopathy: a randomized clinical trial
    Hamid Ahmadieh
    Ophthalmic Research Center, Labbafinejad Medical Center, Shahid Beheshti University, M C, Tehran, Iran
    Ophthalmology 115:1938-43. 2008
  10. pmc Exploratory analysis of diabetic retinopathy progression through 3 years in a randomized clinical trial that compares intravitreal triamcinolone acetonide with focal/grid photocoagulation
    Neil M Bressler
    Jaeb Center for Health Research, 15310 Amberly Dr, STE 350, Tampa, FL 33647, USA
    Arch Ophthalmol 127:1566-71. 2009

Research Grants

  1. MECHANICAL STIMULATION OF IVD CELLS
    Lori A Setton; Fiscal Year: 2013
  2. Bioequivalence of topical drug products: in vitro - in vivo correlations
    Audra L Stinchcomb; Fiscal Year: 2013
  3. Vascular Remodeling and Effects of Angiogenic Inhibition
    Patricia Parsons Wingerter; Fiscal Year: 2006
  4. Vacsular Remodeling and Effects of Angiogenic Inhibition in Diabetic Retinopathy
    Peter Kaiser; Fiscal Year: 2006
  5. CHROMATIN-GLUCOCORTICOID INFLUENCES IN CLEFT PALATE
    ISAAC BEKHOR; Fiscal Year: 1980
  6. OCULAR MELANOMA
    Judy Kim; Fiscal Year: 2003
  7. ASTHMA CLINICAL RESEARCH NETWORK
    Elliot Israel; Fiscal Year: 2002
  8. Apoptosis in Retinal Detachments
    David Zacks; Fiscal Year: 2006
  9. LUNG HEALTH STUDY--LONG TERM FOLLOW UP
    Donald Tashkin; Fiscal Year: 2002
  10. Micromass Quattro API TSQ For LC-MS/MS Quantitation
    Walter Hubbard; Fiscal Year: 2002

Detail Information

Publications309 found, 100 shown here

  1. pmc Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema
    Michael J Elman
    Elman Retina Group, PA, Baltimore, Maryland, USA
    Ophthalmology 118:609-14. 2011
    ..5 mg ranibizumab or 4 mg triamcinolone combined with focal/grid laser compared with focal/grid laser alone for treatment of diabetic macular edema (DME)...
  2. ncbi Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion
    Xiaoyan Ding
    State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat Sen University, Guangzhou, China
    Retina 31:838-45. 2011
    To compare the efficacy and safety of intravitreal triamcinolone acetonide (IVT) versus intravitreal bevacizumab (IVB) for the treatment of macular edema (ME) secondary to central retinal vein occlusion.
  3. ncbi PAMAM-triamcinolone acetonide conjugate as a nucleus-targeting gene carrier for enhanced transfer activity
    Kun Ma
    Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, PR China
    Biomaterials 30:6109-18. 2009
    ..In this research, the two different degrees of substitution of PAMAM-triamcinolone acetonide (PAMAM-TA) conjugates were synthesised for efficient translocation of pDNA into the nucleus...
  4. ncbi Macular grid photocoagulation after intravitreal triamcinolone acetonide for diffuse diabetic macular edema
    Se Woong Kang
    Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 135 710, Korea
    Arch Ophthalmol 124:653-8. 2006
    To evaluate the clinical outcomes of macular laser photocoagulation after the intravitreal injection of 4 mg of triamcinolone acetonide (IVTA) for diffuse diabetic macular edema (DME).
  5. pmc Intravitreal triamcinolone acetonide inhibits breakdown of the blood-retinal barrier through differential regulation of VEGF-A and its receptors in early diabetic rat retinas
    Xinyuan Zhang
    Save Sight Institute, Department of Clinical Ophthalmology, University of Sydney, Sydney, Australia
    Diabetes 57:1026-33. 2008
    ..steroid therapy on diabetic macular edema, we investigated the effect of locally administered triamcinolone acetonide (TA) on the expression of vascular endothelial growth factor (VEGF)-A and its receptors in retinas of ..
  6. ncbi Randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus macular photocoagulation in diabetic macular edema
    Masoud Soheilian
    Ophthalmology Department, Labbafinejad Medical Center, Shaheed Beheshti Medical University, Tehran, Iran
    Ophthalmology 116:1142-50. 2009
    To compare the results of intravitreal bevacizumab (IVB) injection alone or in combination with intravitreal triamcinolone acetonide (IVT) versus macular laser photocoagulation (MPC) as a primary treatment of diabetic macular edema (DME).
  7. ncbi Cytomegalovirus retinitis after intravitreous triamcinolone in an immunocompetent patient
    Michael A Saidel
    Francis I Proctor Foundation, University of California at San Francisco, 95 Kirkham Street, San Francisco, CA 94143, USA
    Am J Ophthalmol 140:1141-3. 2005
    To report the case of a 75-year-old man with diabetes who developed cytomegalovirus (CMV) retinitis after intravitreous injection of triamcinolone acetonide (IVTA).
  8. ncbi Cytomegalovirus retinitis following intravitreal injection of triamcinolone: report of two cases
    Marie Noelle Delyfer
    Vitreo Retinal Unit, Department of Ophthalmology, Bordeaux Univeristy Hospital, Bordeaux, France
    Acta Ophthalmol Scand 85:681-3. 2007
    ..Cytomegalovirus (CMV) retinitis usually affects severely immunosuppressed individuals. However, some exceptional and isolated cases of CMV retinitis have been described in immunocompetent patients...
  9. ncbi Triamcinolone acetonide in silicone-filled eyes as adjunctive treatment for proliferative vitreoretinopathy: a randomized clinical trial
    Hamid Ahmadieh
    Ophthalmic Research Center, Labbafinejad Medical Center, Shahid Beheshti University, M C, Tehran, Iran
    Ophthalmology 115:1938-43. 2008
    To evaluate the effect of adjunctive intraocular triamcinolone acetonide (TA) in silicone-filled eyes on outcomes of vitreoretinal surgery for proliferative vitreoretinopathy (PVR).
  10. pmc Exploratory analysis of diabetic retinopathy progression through 3 years in a randomized clinical trial that compares intravitreal triamcinolone acetonide with focal/grid photocoagulation
    Neil M Bressler
    Jaeb Center for Health Research, 15310 Amberly Dr, STE 350, Tampa, FL 33647, USA
    Arch Ophthalmol 127:1566-71. 2009
    To compare the effect of intravitreal triamcinolone acetonide with focal/grid photocoagulation on the progression of diabetic retinopathy.
  11. pmc Factors associated with improvement and worsening of visual acuity 2 years after focal/grid photocoagulation for diabetic macular edema
    Lloyd Paul Aiello
    Joslin Diabetes Center and Department of Ophthalmology, Harvard Medical School, Cambridge, Massachusetts, USA
    Ophthalmology 117:946-53. 2010
    ..net) trial comparing triamcinolone with focal/grid laser...
  12. ncbi Five-year results of a randomized trial with open-label extension of triamcinolone acetonide for refractory diabetic macular edema
    Mark C Gillies
    Department of Clinical Ophthalmology and Eye Health, Save Sight Institute, The University of Sydney, Australia
    Ophthalmology 116:2182-7. 2009
    To report 5-year outcomes from a clinical trial of intravitreal triamcinolone acetonide (IVTA) in eyes with diabetic macular edema (DME) and impaired vision despite previous laser treatment.
  13. ncbi Triamcinolone acetonide and hexacetonide intra-articular treatment of symmetrical joints in juvenile idiopathic arthritis: a double-blind trial
    F Zulian
    Rheumatology Unit, Department of Paediatrics, University Hospital of Padua, Via Giustiniani 3, 35128 Padova, Italy
    Rheumatology (Oxford) 43:1288-91. 2004
    Pharmacokinetic studies have shown that the biological effect of triamcinolone acetonide (TA) is equivalent to that of triamcinolone hexacetonide (TH), if used at double the dosage...
  14. pmc Comparison of the short-term effects of intravitreal triamcinolone acetonide and bevacizumab injection for diabetic macular edema
    Ju Hwan Song
    Department of Ophthalmology, Kosin University College of Medicine, Busan, Korea
    Korean J Ophthalmol 25:156-60. 2011
    To compare the short-term effects of intravitreal triamcinolone acetonide (IVTA) with those of intravitreal bevacizumab (IVB) injection for diabetic macular edema (DME).
  15. ncbi Intraocular pressure elevation after intravitreal triamcinolone acetonide injection
    Jost B Jonas
    Department of Ophthalmology, Faculty of Clinical Medicine Mannheim of the University Heidelberg, Heidelberg, Germany
    Ophthalmology 112:593-8. 2005
    To report on intraocular pressure (IOP) after intravitreal injections of triamcinolone acetonide.
  16. ncbi A rabbit model for assessing the ocular barriers to the transscleral delivery of triamcinolone acetonide
    Michael R Robinson
    National Eye Institute, National Institutes of Health, Bethesda, MD, USA
    Exp Eye Res 82:479-87. 2006
    Transscleral delivery of triamcinolone acetonide into the vitreous using sub-Tenon's injections may be a safer alternative to reduce the sight-threatening complications of direct intravitreal injections...
  17. ncbi Combined laser and intravitreal triamcinolone for proliferative diabetic retinopathy and macular edema: one-year results of a randomized clinical trial
    Otacilio O Maia
    Department of Ophthalmology, Hospital Sao Rafael, Monte Tabor Foundation, Salvador, BA, Brazil
    Am J Ophthalmol 147:291-297.e2. 2009
    To evaluate laser combined with intravitreal triamcinolone acetonide (IVTA) for the management of patients with proliferative diabetic retinopathy (PDR) and clinically significant macular edema (CSME).
  18. ncbi Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative diabetic retinopathy
    J B Jonas
    Department of Ophthalmology and Eye Hospital, Faculty of Clinical Medicine, Mannheim of the Ruprecht Karls University, Heidelberg, Germany
    Am J Ophthalmol 131:468-71. 2001
    ..To report the clinical outcome and complications of intravitreal injections of crystalline cortisone in patients undergoing pars plana vitrectomy for treatment of proliferative diabetic retinopathy...
  19. ncbi Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema
    Jose A Cardillo
    Hospital de Olhos de Araraquara, Araraquara, Sao Paulo, Brazil
    Ophthalmology 112:1557-63. 2005
    To compare the safety and efficacy of intravitreal versus posterior Sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.
  20. ncbi Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edema
    Masahiko Shimura
    Department of Ophthalmology, NTT East Japan Tohoku Hospital, Sendai, Miyagi, Japan
    Am J Ophthalmol 145:854-61. 2008
    To compare the effect of an intravitreal injection of bevacizumab, an anti-vascular endothelial growth factor (VEGF) antibody, with that of triamcinolone acetonide, a corticosteroid for reduction of diabetic macular edema (DME).
  21. ncbi Intravitreal bevacizumab versus triamcinolone acetonide for refractory uveitic cystoid macular edema: a randomized pilot study
    Masoud Soheilian
    Ophthalmology Department and Ophthalmic Research Center, Labbafinejad Medical Center, Shaheed Beheshti Medical University, Tehran, Iran
    J Ocul Pharmacol Ther 26:199-206. 2010
    To compare intravitreal bevacizumab (IVB) versus intravitreal triamcinolone acetonide (IVT) for treatment of refractory uveitic cystoid macular edema (CME).
  22. ncbi Triple therapy of vitrectomy, intravitreal triamcinolone, and macular laser photocoagulation for intractable diabetic macular edema
    Se Woong Kang
    Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
    Am J Ophthalmol 144:878-885. 2007
    ..To evaluate the effect of a sequentially combined triple therapy on intractable diabetic macular edema (DME)...
  23. ncbi Microperimetric changes after intravitreal triamcinolone acetonide injection for macular edema due to central retinal vein occlusion
    Fevzi Senturk
    The Istanbul Retina Institute, Istanbul, Turkey
    Retina 30:1254-61. 2010
    The purpose of this study was to evaluate the effect of intravitreal triamcinolone acetonide on macular function in cases of macular edema because of central retinal vein occlusion.
  24. ncbi Triamcinolone acetonide as an adjuvant in the surgical treatment of retinal detachment with proliferative vitreoretinopathy
    Rizwan A Cheema
    Cardiff Eye Unit, University Hospital of Wales, Cardiff, United Kingdom
    Ophthalmic Surg Lasers Imaging 38:365-70. 2007
    To report the efficacy of intravitreal triamcinolone acetonide as an adjuvant in the surgical management of cases with advanced proliferative vitreoretinopathy (PVR).
  25. ncbi Selective nerve root blocks for the treatment of sciatica: evaluation of injection site and effectiveness--a study with patients and cadavers
    C W Pfirrmann
    Department of Radiology, University Hospital Balgrist, Forchstrasse 340, Ch 8008 Zurich, Switzerland
    Radiology 221:704-11. 2001
    ..To relate different types of radiographic contrast material distributions to anatomic compartments by using cadaveric specimens and to relate the injection site to treatment-induced discomfort and therapeutic effect...
  26. ncbi Toxicity of triamcinolone acetonide on retinal neurosensory and pigment epithelial cells
    Raja Narayanan
    Department of Ophthalmology, School of Medicine, University of California, Irvine, California 92697, USA
    Invest Ophthalmol Vis Sci 47:722-8. 2006
    To study the toxicity of triamcinolone acetonide (Kenalog; Bristol-Meyers Squibb, Princeton, NJ) on retinal pigment epithelial (ARPE-19) and retinal neurosensory (R28) cells.
  27. ncbi Vitreous concentrations of triamcinolone acetonide in human eyes after intravitreal or subtenon injection
    Makoto Inoue
    Department of Ophthalmology, Keio University School of Medicine, Tokyo, Japan
    Am J Ophthalmol 138:1046-8. 2004
    To compare vitreous concentrations of triamcinolone acetonide (TA) achieved by prior therapeutic intravitreal and subtenon injections.
  28. pmc Randomized trial evaluating short-term effects of intravitreal ranibizumab or triamcinolone acetonide on macular edema after focal/grid laser for diabetic macular edema in eyes also receiving panretinal photocoagulation
    Joseph Googe
    Southeastern Retina Associates, P C, Knoxville, Tennessee, USA
    Retina 31:1009-27. 2011
    ..To evaluate 14-week effects of intravitreal ranibizumab or triamcinolone in eyes receiving focal/grid laser for diabetic macular edema and panretinal photocoagulation...
  29. pmc Development of a gene therapy virus with a glucocorticoid-inducible MMP1 for the treatment of steroid glaucoma
    Maria Grazia Spiga
    Department of Ophthalmology, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599 7041, USA
    Invest Ophthalmol Vis Sci 51:3029-41. 2010
    ..To design a glucocorticoid-inducible virus vector overexpressing recombinant matrix metalloproteinase 1 (MMP1) and counteract extracellular matrix deposition in the trabecular meshwork only when steroid is present...
  30. ncbi Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study
    R J Antcliff
    GKT Department of Ophthalmology, Rayne Institute, St Thomas' Hospital, Lambeth Palace Road, London SE1 7EH, England, UK
    Ophthalmology 108:765-72. 2001
    PURPOSE: To investigate the use of intravitreal injection of triamcinolone acetonide (TA) for the treatment of refractory uveitic cystoid macular edema (CME). DESIGN: Prospective, nonrandomized, self-controlled comparative trial...
  31. ncbi Intravitreal triamcinolone plus sequential grid laser versus triamcinolone or laser alone for treating diabetic macular edema: six-month outcomes
    Dennis S C Lam
    Department of Ophthalmology and Visual Sciences, Chinese University of Hong Kong, Hong Kong, China
    Ophthalmology 114:2162-7. 2007
    To evaluate the efficacy of sequential intravitreal triamcinolone acetonide (TA) injection followed by grid laser photocoagulation for treating diabetic macular edema (DME).
  32. ncbi Intravitreal triamcinolone versus bevacizumab for treatment of refractory diabetic macular oedema (IBEME study)
    L Paccola
    Department of Ophthalmology, School of Medicine of Ribeirao Preto, Ribeirao Preto, SP, Brazil
    Br J Ophthalmol 92:76-80. 2008
    ..aim of this study was to compare the morphological and visual acuity outcomes associated with a single intravitreal injection of triamcinolone acetonide versus bevacizumab for the treatment of refractory diffuse diabetic macular oedema.
  33. ncbi Neuroprotective effect of intravitreal triamcinolone acetonide against photoreceptor apoptosis in a rabbit model of subretinal hemorrhage
    Robert B Bhisitkul
    Department of Ophthalmology, Epidemiology and Biostatistics Division, University of California at San Francisco, School of Medicine, San Francisco, California, USA
    Invest Ophthalmol Vis Sci 49:4071-7. 2008
    To study photoreceptor apoptosis and iron migration as mechanisms of retinotoxicity in a rabbit model of subretinal hemorrhage (SRH) and to assess intravitreal triamcinolone acetonide (IVTA) for anti-apoptotic and neuroprotective effects.
  34. ncbi Prevention of relapses of nasal polyposis with intranasal triamcinolone acetonide after polyp surgery: a prospective double-blind, placebo-controlled, randomised study with a 9-month follow-up
    S I Vento
    Department of Otorhinolaryngology Head and Neck Surgery, Helsinki University, Central Hospital, Helsinki, Finland
    Clin Otolaryngol 37:117-23. 2012
    To determine whether intranasal triamcinolone acetonide prevents the regrowth of nasal polyps after polyp surgery.
  35. ncbi A comparison of the combined effect of cryotherapy and corticosteroid injections versus corticosteroids and cryotherapy alone on keloids: a controlled study
    G Yosipovitch
    National Skin Centre, National Medical Research Council, Ministry of Health, Singapore
    J Dermatolog Treat 12:87-90. 2001
    ..Few studies have been performed in a controlled fashion to evaluate the efficacy of these treatments...
  36. pmc Triamcinolone acetonide decreases outflow facility in C57BL/6 mouse eyes
    Sandeep Kumar
    Department of Cell Biology, SUNY Downstate Medical Center, Brooklyn, NY 11203, USA
    Invest Ophthalmol Vis Sci 54:1280-7. 2013
    To determine the effect of triamcinolone acetonide (TA) on outflow facility in mice.
  37. ncbi Surgical and anatomical outcomes of pars plana vitrectomy for diffuse nontractional diabetic macular edema
    Marta S Figueroa
    Department of Ophthalmology, Ramon y Cajal Hospital, Madrid, Spain
    Retina 28:420-6. 2008
    To prospectively determine the efficacy of vitrectomy combined with intravitreal triamcinolone acetonide (IVTA) injection, internal limiting membrane (ILM) peeling, or both in treating diffuse nontractional diabetic macular edema (ME).
  38. ncbi Release profile and transscleral permeation of triamcinolone acetonide loaded nanostructured lipid carriers (TA-NLC): in vitro and ex vivo studies
    Joana Araújo
    Department of Physical Chemistry, Faculty of Pharmacy, University of Barcelona, Barcelona, Spain
    Nanomedicine 8:1034-41. 2012
    Nanostructured lipid carriers (NLC) have been developed for sustained release of triamcinolone acetonide (TA), a corticosteroid commonly indicated for macular edema, neovascularization, and other ocular inflammatory disorders...
  39. ncbi Safety of intravitreal high-dose reinjections of triamcinolone acetonide
    Jost B Jonas
    Department of Ophthalmology and Eye Hospital, Medical Faculty Mannheim of the Ruprecht Karls University Heidelberg, Germany
    Am J Ophthalmol 138:1054-5. 2004
    To report side effects after intravitreal high-dose reinjections of triamcinolone acetonide.
  40. ncbi Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases
    Jost B Jonas
    Department of Ophthalmology, Faculty of Clinical Medicine Mannheim, Ruprecht Karls University of Heidelberg, Germany
    Acta Ophthalmol Scand 83:645-63. 2005
    Intravitreal triamcinolone acetonide (IVTA) has increasingly been applied as treatment for various intraocular neovascular and oedematous diseases...
  41. ncbi Effect of triamcinolone acetonide on vascular endothelial growth factor and occludin levels in branch retinal vein occlusion
    Ian L McAllister
    Lions Eye Institute, Centre for Ophthalmology and Visual Science, The University of Western Australia, Perth, Australia
    Am J Ophthalmol 147:838-46, 846.e1-2. 2009
    To investigate the molecular mechanism by which triamcinolone acetonide (TA) may reduce edema in a porcine model of branch retinal vein occlusion (BRVO).
  42. ncbi Long-term retinal toxicity of intravitreal commercially available preserved triamcinolone acetonide (Kenalog) in rabbit eyes
    Thomas A Albini
    Cullen Eye Institute, Baylor College of Medicine, Houston, Texas 77030, USA
    Invest Ophthalmol Vis Sci 48:390-5. 2007
    ..To investigate whether intravitreal Kenalog (IVTK; Bristol Meyers Squibb Company, Princeton, NJ) produces histologic or electroretinographic changes in the rabbit retina up to 3 months after injection...
  43. ncbi Severe steroid-induced glaucoma following intravitreal injection of triamcinolone acetonide
    Polly A Quiram
    Jules Stein Eye Institute, David Geffen UCLA School of Medicine, 100 Stein Plaza, Los Angeles, CA 90095, USA
    Am J Ophthalmol 141:580-2. 2006
    ..To report a case of severe corticosteroid-induced glaucoma after intravitreal injection of triamcinolone acetate in a 34-year-old man without a history of glaucoma...
  44. pmc Glycyrrhizin could reduce ocular hypertension induced by triamcinolone acetonide in rabbits
    Zhengyu Song
    Shanghai First People s Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, P R China
    Mol Vis 17:2056-64. 2011
    To evaluate the hypotensive effects of glycyrrhizin (GL) on a rabbit model of ocular hypertension (OH) induced by triamcinolone acetonide (TA).
  45. ncbi Visual outcome after intravitreal triamcinolone acetonide depends on optical coherence tomographic patterns in patients with diffuse diabetic macular edema
    Masahiko Shimura
    Department of Ophthalmology, NTT East Japan Tohoku Hospital, Sendai, Miyagi, Japan
    Retina 31:748-54. 2011
    To evaluate the effectiveness of intravitreal triamcinolone acetonide (IVTA) on the reduction of diffuse diabetic macular edema with different optical coherence tomographic patterns.
  46. ncbi Effectiveness of instillation of triamcinolone acetonide into the middle ear for eosinophilic otitis media associated with bronchial asthma
    Yukiko Iino
    Department of Otolaryngology, Teikyo University School of Medicine, Tokyo, Japan
    Ann Allergy Asthma Immunol 97:761-6. 2006
    ..To our knowledge, no systemic study regarding the efficacy of treatments for EOM has been performed...
  47. pmc Intravitreal triamcinolone acetonide for ischaemic macular oedema caused by branch retinal vein occlusion
    S D M Chen
    Br J Ophthalmol 88:154-5. 2004
  48. pmc Pars plana vitrectomy assisted by triamcinolone acetonide for refractory uveitis: a case series study
    K H Sonoda
    Department of Ophthalmology, Kyushu University Graduate School of Medicine, Fukuoka, Japan
    Br J Ophthalmol 87:1010-4. 2003
    To examine the outcome of a triamcinolone acetonide (TA) assisted pars plana vitrectomy (PPV) for refractory uveitis.
  49. ncbi The relationship of intracanal medicaments to postoperative pain in endodontics
    E H Ehrmann
    School of Dental Science, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, 711 Elizabeth Street, Melbourne, Victoria, 3000, Australia
    Int Endod J 36:868-75. 2003
    ..To investigate the relationship of postoperative pain to three different medicaments placed in the root canal after a complete biomechanical debridement of the root canal system in patients presenting for emergency relief of pain...
  50. ncbi Posterior sub-tenon triamcinolone for refractory diabetic macular edema: a randomized clinical trial
    M Entezari
    Department of Ophthalmology, Emam Hossein Medical Center, Tehran, Iran
    Eur J Ophthalmol 15:746-50. 2005
    To evaluate the effect of posterior sub-tenon triamcinolone acetonide (TA) injection on clinical, angiographic, and optical coherence tomographic (OCT) parameters in refractory diabetic macular edema (DME).
  51. ncbi Periocular triamcinolone acetonide injections for cystoid macular edema complicating noninfectious uveitis
    Henry A Leder
    Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Am J Ophthalmol 152:441-448.e2. 2011
    ..To describe the effectiveness of periocular corticosteroid injections in the treatment of cystoid macular edema (CME) complicating noninfectious uveitis...
  52. ncbi Cytotoxicity of triamcinolone acetonide on human retinal pigment epithelial cells
    Yi Sheng Chang
    Department of Ophthalmology, College of Medicine, National Cheng Kung University, Taiwan
    Invest Ophthalmol Vis Sci 48:2792-8. 2007
    To investigate the toxic effects of triamcinolone acetonide (TA) suspensions on human retinal pigment epithelial (RPE) cells.
  53. ncbi Topical treatment of the buccal mucosa and wounded skin in rats with a triamcinolone acetonide-loaded hydrogel prepared using an electron beam
    Soon Gil Choi
    College of Pharmacy, Chungnam National University, Daejeon 305 764, Republic of Korea
    Int J Pharm 447:102-8. 2013
    In this study, a triamcinolone acetonide-loaded hydrogel was prepared by electron beam irradiation and evaluated for use as a buccal mucoadhesive drug delivery system...
  54. ncbi The effect of short-term exposure of triamcinolone acetonide on fibroblasts and retinal pigment epithelial cells
    Jaeryung Oh
    Department of Ophthalmology, Guro Hospital, Korea University, Seoul, Korea
    Acta Ophthalmol Scand 85:786-90. 2007
    ..We investigated the effects of short-term exposure to triamcinolone on cultured choroidal fibroblast (CFB) cells and retinal pigment epithelial (RPE) cells...
  55. pmc Ocular side effects associated with peribulbar injections of triamcinolone acetonide for diabetic macular edema
    Emily Y Chew
    National Eye Institute National Institutes of Health, Bethesda, Maryland, USA
    Retina 31:284-9. 2011
    To evaluate long-term effects of anterior and posterior peribulbar injections of triamcinolone acetonide on intraocular pressure (IOP) elevation and cataract development.
  56. ncbi Effect of nasal triamcinolone acetonide on seasonal variations of bronchial hyperresponsiveness and bronchial inflammation in nonasthmatic children with seasonal allergic rhinitis
    Fazil Orhan
    Faculty of Medicine, Department of Pediatric Allergy, Hacettepe University, Ankara, Turkey
    Ann Allergy Asthma Immunol 92:438-45. 2004
    ..Recent evidence suggests that patients with allergic rhinitis have lower airway inflammation and a higher prevalence of bronchial hyperresponsiveness (BHR) regardless of asthma...
  57. ncbi Effects of triamcinolone acetonide on microglial morphology and quantitative expression of MHC-II in exudative age-related macular degeneration
    P L Penfold
    Save Sight Institute, Department of Clinical Ophthalmology, University of Sydney, New South Wales, Australia
    Clin Experiment Ophthalmol 29:188-92. 2001
    Animal models, in vitro assays and pilot clinical studies suggest that intravitreal triamcinolone acetonide may be useful in the treatment of age-related macular degeneration...
  58. ncbi Vehicle of triamcinolone acetonide is associated with retinal toxicity and transient increase of lens density
    Wang Kai
    People Eye Centre of People s Hospital, No 11 South Avenue of XiZhiMen, Xicheng District, Beijing, People s Republic of China
    Graefes Arch Clin Exp Ophthalmol 244:1152-9. 2006
    Intravitreal triamcinolone acetonide (TA) has been widely used as a therapeutic method for many ocular diseases, but a consensus on an appropriate safe therapeutic window of dosage for intravitreal injection, and whether vehicle of TA ..
  59. ncbi Efficacy and safety of intravitreal bevacizumab compared with intravitreal and posterior sub-tenon triamcinolone acetonide for treatment of uveitic cystoid macular edema
    Jeong Hun Bae
    Department of Ophthalmology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea
    Retina 31:111-8. 2011
    To demonstrate the effect of bevacizumab compared with triamcinolone acetonide for the treatment of persistent cystoid macular edema in noninfectious uveitis.
  60. ncbi Increased incidence of sterile endophthalmitis following intravitreal preserved triamcinolone acetonide
    J Jonisch
    Department of Ophthalmology, North Shore Long Island Jewish Health System, Great Neck, NY, USA
    Br J Ophthalmol 92:1051-4. 2008
    To report an increased incidence of sterile endophthalmitis following intravitreal injection of preserved triamcinolone acetonide (IVTA) from 1 May to 31 July 2006.
  61. ncbi Intraocular and systemic pharmacokinetics of triamcinolone acetonide after a single 40-mg posterior subtenon application
    Lijun Shen
    Eye Hospital and School of Ophthalmology and Optometry, Wenzhou Medical College, Wenzhou, Zhejiang, China
    Ophthalmology 117:2365-71. 2010
    To characterize the pharmacokinetics of triamcinolone acetonide (TA) in aqueous, vitreous, and systemic circulation after a single subtenon injection.
  62. ncbi Relationship of intracanal medicaments to endodontic flare-ups
    M Trope
    Department of Endodontology, Temple University School of Dentistry, Philadelphia
    Endod Dent Traumatol 6:226-9. 1990
    ..Six of the twelve flare-ups occurred in retreatment cases and the other six occurred in teeth without previous endodontic treatment. No significant difference was found in the flare-up rate among the three intracanal medicaments...
  63. ncbi Nocardia asteroides necrotizing scleritis associated with subtenon triamcinolone acetonide injection
    Rajeev K Seth
    Department of Ophthalmology and Visual Science, Yale University School of Medicine, New Haven, Connecticut 06511, USA
    Ocul Immunol Inflamm 16:139-40. 2008
    To report a case of Nocardia asteroides infection after subtenon triamcinolone acetonide injection.
  64. ncbi Isolating triamcinolone acetonide particles for intravitreal use with a porous membrane filter
    Akira Nishimura
    Department of Ophthlamology, Kanazawa University Graduate School of Medical Science, Ishikawa Prefecture, Japan
    Retina 23:777-9. 2003
    To report a new, simple, rapid method to isolate triamcinolone acetonide particles and to remove additives from its commercially available suspension (Kenacort-A) for intravitreal use.
  65. ncbi Effect of intravitreal triamcinolone acetonide injection on central macular thickness in diabetic patients having phacoemulsification
    Hooshang Faghihi Ahmadabadi
    Department of Ophthalmology, Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran
    J Cataract Refract Surg 36:917-22. 2010
    To assess the effect of intraoperative intravitreal injection of triamcinolone acetonide on the central macular thickness, visual outcomes, and development of cystoid macular edema (CME) after phacoemulsification in diabetic patients.
  66. ncbi Intravitreal triamcinolone prior to laser treatment of diabetic macular edema: 24-month results of a randomized controlled trial
    Mark C Gillies
    Save Sight Institute, The University of Sydney, Sydney, Australia
    Ophthalmology 118:866-72. 2011
    To report the 24 months outcomes from a clinical trial of intravitreal triamcinolone acetonide (IVTA) plus laser versus laser treatment only in eyes with diabetic macular edema (DME).
  67. ncbi Cytomegalovirus retinitis after low-dose intravitreous triamcinolone acetonide in an immunocompetent patient: a warning for the widespread use of intravitreous corticosteroids
    Dora Vertes
    Department of Ophthalmology, UCL, Universitaire Saint Luc Hospital, Av Hippocrate, 10, 1200, Brussels, Belgium
    Int Ophthalmol 30:595-7. 2010
    ..78-year-old woman who developed cytomegalovirus (CMV) retinitis after a single intravitreous injection of triamcinolone acetonide (IVTA). Review of medical records...
  68. ncbi Sterile endophthalmitis following intravitreal injection of triamcinolone acetonide
    Lu Chun Wang
    Department of Ophthalmology, National Taiwan University Hospital NTUH, Taipei, Taiwan
    Ocul Immunol Inflamm 13:295-300. 2005
    ..To investigate clinical findings and ocular characteristics of sterile endophthalmitis following intravitreal injection (IVI) of triamcinolone for the treatment of macular edema...
  69. ncbi Pseudohypopyon following intravitreal triamcinolone acetonide injection
    Mithlesh C Sharma
    Vitreoretina Service, Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago Eye and Ear Infirmary, Chicago, IL 60612, USA
    Cornea 23:398-9. 2004
    To report a case of a pseudohypopyon that developed after intravitreal injection of triamcinolone acetonide for choroidal neovascularization from age-related macular degeneration.
  70. ncbi Intravitreal and orbital floor triamcinolone acetonide injections in noninfectious uveitis: a comparative study
    Martin Roesel
    Department of Ophthalmology, St Franziskus Hospital, University Duisburg Essen, DE 48145 Münster, Germany
    Ophthalmic Res 42:81-6. 2009
    To compare the effect of orbital floor (OFTA) or intravitreal (IVTA) administration of triamcinolone acetonide on visual acuity and chronic cystoid macular edema (CME) in patients with uveitis.
  71. ncbi Intramuscular botulinum toxin-A reduces hemiplegic shoulder pain: a randomized, double-blind, comparative study versus intraarticular triamcinolone acetonide
    Jae Young Lim
    Department of Rehabilitation Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, 300 Gumi dong, Bundang gu, Seongnam si, Gyeonggi Do, 463 707, South Korea
    Stroke 39:126-31. 2008
    ..randomized, double-blind controlled study was conducted to compare the efficacies of botulinum toxin type A (BoNT-A) and triamcinolone acetonide (TA) on hemiplegic shoulder pain and their effects on arm function in patients with stroke.
  72. ncbi Short-term results of a single intravitreal bevacizumab (avastin) injection versus a single intravitreal triamcinolone acetonide (kenacort) injection for the management of refractory noninfectious uveitic cystoid macular edema
    Andres F Lasave
    Retina and Vitreous Service, Clinica Oftalmologica Centro Caracas, Caracas, Venezuela
    Ocul Immunol Inflamm 17:423-30. 2009
    To report the short-term results of a single intravitreal injection of bevacizumab (IVB) versus a single intravitreal injection of triamcinolone acetonide (IVT) to treat refractory noninfectious uveitic cystoid macular edema (CME).
  73. ncbi The natural history of sciatica associated with disc pathology. A prospective study with clinical and independent radiologic follow-up
    K Bush
    Orthopaedic Medical Practice, London, United Kingdom
    Spine (Phila Pa 1976) 17:1205-12. 1992
    ..Only a small proportion of patients needed surgical decompression...
  74. ncbi Intravitreal diclofenac versus intravitreal triamcinolone acetonide in the treatment of diabetic macular edema
    Amal M Elbendary
    Mansoura Ophthalmic Center, Mansoura University, Mansoura, Egypt
    Retina 31:2058-64. 2011
    To compare the efficacy and safety of intravitreal diclofenac versus intravitreal triamcinolone acetonide in the treatment of diabetic macular edema.
  75. ncbi Intravitreal triamcinolone acetonide injection at the end of vitrectomy for diabetic vitreous hemorrhage: a randomized, clinical trial
    Hooshang Faghihi
    Department of Ophthalmology, School of Medicine, Medical Sciences, Tehran University, Tehran, Iran
    Retina 28:1241-6. 2008
    To evaluate the clinical outcome and complications of intravitreal injections of triamcinolone acetonide in patients undergoing pars plana vitrectomy for treatment of diabetic nonclearing vitreous hemorrhage.
  76. pmc Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of choroidal neovascularisation secondary to pathological myopia: a pilot study
    Javier A Montero
    Br J Ophthalmol 91:131-3. 2007
  77. ncbi Repeat intrathecal triamcinolone acetonide application is beneficial in progressive MS patients
    V Hoffmann
    Department of Neurology, Kamillus Klinik, Asbach, and Department of Neurology, St Josef Hospital, Ruhr University, Bochum, Germany
    Eur J Neurol 13:72-6. 2006
    ..trial on the short-term efficacy of repeated intrathecal application of the sustained release steroid triamcinolone acetonide (TCA) in 27 progressive MS patients...
  78. ncbi Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial
    Florian K P Sutter
    Save Sight Institute, Department of Clinical Ophthalmology and Eye Health, The University of Sydney, Sydney, NSW, Australia
    Ophthalmology 111:2044-9. 2004
    To determine whether an intravitreal injection of triamcinolone acetonide for persistent diabetic macular edema after adequate laser treatment improves visual acuity.
  79. pmc Treatment of sheep steroid-induced ocular hypertension with a glucocorticoid-inducible MMP1 gene therapy virus
    Rosana Gerometta
    Departamento de Oftalmologia, UNNE, Corrientes, Argentina
    Invest Ophthalmol Vis Sci 51:3042-8. 2010
    ..To investigate whether intracameral injection of the adenovirus vector AdhGRE.MMP1 would reduce or prevent elevated intraocular pressure (IOP) induced by corticosteroids in living animals...
  80. ncbi Treatment of cystoid macular edema related to retinitis pigmentosa with intravitreal triamcinolone acetonide
    Vinicius S Saraiva
    Department of Ophthalmology, Federal University of Sao Paulo, Sao Paulo, Brazil
    Ophthalmic Surg Lasers Imaging 34:398-400. 2003
    A case of cystoid macular edema related to retinitis pigmentosa treated with intravitreal injection of triamcinolone acetonide is described...
  81. ncbi Difference in clearance of intravitreal triamcinolone acetonide between vitrectomized and nonvitrectomized eyes
    Hee Seung Chin
    Department of Ophthalmology, Inha University Hospital, Inchon, South Korea
    Retina 25:556-60. 2005
    To study the difference in clearance of intravitreal triamcinolone acetonide quantitatively between vitrectomized and nonvitrectomized eyes.
  82. ncbi Intravitreal triamcinolone acetonide injection for treatment of refractory diabetic macular edema: a systematic review
    Taygan Yilmaz
    The Dartmouth Institute for Health Policy and Clinical Practice, 30 Lafayette Street, Hanover, NH 03766, USA
    Ophthalmology 116:902-11; quiz 912-3. 2009
    To compare intravitreal triamcinolone acetonide (IVTA) injection versus no treatment or sub-Tenon triamcinolone acetonide (STTA) injection in improving visual acuity (VA) of patients with refractory diabetic macular edema (DME; ..
  83. ncbi Intravitreal triamcinolone-induced elevated intraocular pressure is associated with the development of posterior subcapsular cataract
    Mark C Gillies
    Save Sight and Eye Health Institute, University of Sydney, NSW, Australia
    Ophthalmology 112:139-43. 2005
    ..To investigate the association between elevated intraocular pressure (IOP) and accelerated cataract formation in patients treated with intravitreal triamcinolone...
  84. ncbi Triamcinolone as adjunctive treatment to laser panretinal photocoagulation for proliferative diabetic retinopathy
    Francesco Bandello
    Department of Ophthalmology, University of Udine, Piazzale Santa Maria della Misericordia, 33100 Udine, Italy
    Arch Ophthalmol 124:643-50. 2006
    To evaluate intravitreal injection of triamcinolone acetonide before laser panretinal photocoagulation (PRP) in the treatment of proliferative diabetic retinopathy.
  85. ncbi Intravitreal triamcinolone acetonide for treatment of cystoid macular oedema in patients with retinitis pigmentosa
    Hakan Ozdemir
    Istanbul Retina Institute Inc, Istanbul, Turkey
    Acta Ophthalmol Scand 83:248-51. 2005
    To evaluate the anatomic and visual outcomes of intravitreal triamcinolone acetonide injection in patients with cystoid macular oedema (CMO) secondary to retinitis pigmentosa (RP).
  86. ncbi Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema
    J B Jonas
    Department of Ophthalmology and Eye Hospital, Faculty of Clinical Medicine Mannheim, University of Heidelberg, Heidelberg, Germany
    Am J Ophthalmol 132:425-7. 2001
    ..To report the clinical outcome of a diabetic patient with macular edema treated with an intravitreal injection of crystalline cortisone...
  87. ncbi Effects of periocular administration of triamcinolone acetonide on leukocyte-endothelium interactions in the ischemic retina
    Shimon Mizuno
    Department of Ophthalmology and Visual Sciences, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
    Invest Ophthalmol Vis Sci 48:2831-6. 2007
    Recent studies have reported that intravitreal or posterior sub-Tenon's injection of triamcinolone acetonide (TA) is effective in the treatment of macular edema resulting from retinal microcirculatory disturbances such as diabetic ..
  88. pmc Effects of intravitreal triamcinolone acetonide injection with and without preservative
    Mauricio Maia
    Federal University of Sao Paulo, Department of Ophthalmology, Vision Institute, Sao Paulo, Brazil
    Br J Ophthalmol 91:1122-4. 2007
    To evaluate the effects of intravitreal injection of preservative-free triamcinolone acetonide (PFTA) and TA containing preservative (KE).
  89. ncbi Secondary ocular hypertension after intravitreal injection of 4 mg of triamcinolone acetonide: incidence and risk factors
    Daniel V Vasconcelos-Santos
    Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil
    Retina 28:573-80. 2008
    To analyze the incidence of secondary ocular hypertension (SOH) after intravitreal triamcinolone acetonide (IVTA) injection and its risk predictors.
  90. ncbi Glucocorticoids induce retinal toxicity through mechanisms mainly associated with paraptosis
    Fatemeh Valamanesh
    INSERM, Physiopathology of ocular diseases therapeutic innovations, Institut des Cordeliers, Universite Rene Descartes, Paris, France
    Mol Vis 13:1746-57. 2007
    ..The mechanism of these toxic events remains, however, poorly understood. In our present study, we investigated the mechanisms and potential pathways of corticosteroid-induced retinal cell death...
  91. ncbi Intraocular availability of triamcinolone acetonide after intravitreal injection
    Jost B Jonas
    Department of Ophthalmology, Faculty for Clinical Medicine Mannheim, Ruprecht Karls University, Heidelberg, Germany
    Am J Ophthalmol 137:560-2. 2004
    To evaluate the intraocular concentration of triamcinolone acetonide after intravitreal injection.
  92. ncbi Safety profile of intravitreal triamcinolone acetonide
    J Baath
    Undergraduate Medicine, University of Toronto, Toronto, Ontario, Canada
    J Ocul Pharmacol Ther 23:304-10. 2007
    There is currently a widespread use of intravitreal triamcinolone acetonide (IVTA) for age-related macular degeneration, diabetic macular edema, cystoid macular edema secondary to retinal vein occlusions, and uveitis...
  93. ncbi Branch retinal vein occlusion treated by intravitreal triamcinolone acetonide
    J B Jonas
    Department of Ophthalmology and Eye Hospital, Faculty for Clinical Medicine, Mannheim Ruprecht Karls University, Heidelberg, Germany
    Eye (Lond) 19:65-71. 2005
    To evaluate the effect of intravitreal triamcinolone acetonide on visual acuity in branch retinal vein occlusion.
  94. pmc Randomized trial of peribulbar triamcinolone acetonide with and without focal photocoagulation for mild diabetic macular edema: a pilot study
    E Chew
    Ophthalmology 114:1190-6. 2007
    ..To provide pilot data on the safety and efficacy of anterior and posterior sub-Tenon injections of triamcinolone either alone or in combination with focal photocoagulation in the treatment of mild diabetic macular edema (DME)...
  95. ncbi Intravitreal triamcinolone for diabetic macular oedema in Chinese patients: six-month prospective longitudinal pilot study
    Dennis S C Lam
    Department of Ophthalmology and Visual Sciences, Chinese University of Hong Kong, Hong Kong Eye Hospital, Hong Kong
    Clin Experiment Ophthalmol 32:569-72. 2004
    ..To evaluate the safety and efficacy of intravitreal triamcinolone (IVTA) in Chinese patients with diabetic clinical significant macular oedema (CSMO)...
  96. pmc Viral retinitis after intravitreal triamcinolone injection in patients with predisposing medical comorbidities
    Ankur M Shah
    Jacobs Retina Center, Department of Ophthalmology, University of California, San Diego, La Jolla, California 92093, USA
    Am J Ophthalmol 149:433-40.e1. 2010
    ..To review the cases of viral retinitis after intravitreal steroid administration at a single center, to estimate the incidence, and to propose risk factors for its occurrence...
  97. ncbi Comparison of intravitreal triamcinolone acetonide with photodynamic therapy and intravitreal bevacizumab with photodynamic therapy for retinal angiomatous proliferation
    Masaaki Saito
    Department of Ophthalmology, Fukushima Medical University School of Medicine, Fukushima, Japan
    Am J Ophthalmol 149:472-81.e1. 2010
    ....
  98. pmc A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlu
    Ingrid U Scott
    EMMES Corporation, Rockville, MD 20850, USA
    Arch Ophthalmol 127:1115-28. 2009
    ....
  99. ncbi The effect of intracanal anti-inflammatory medicaments on external root resorption of replanted dog teeth after extended extra-oral dry time
    H Chen
    Private Practice, Durham, NC, USA
    Dent Traumatol 24:74-8. 2008
    ..8%; 69.8%; 52.4%) and more remaining root structure (5.59; 5.48; 5.09) than the group filled with GP and sealer (positive control) (0; 1.15). Corticosteroids were as effective as Ledermix at inhibiting external root resorption...
  100. ncbi Randomized trial of pimecrolimus cream versus triamcinolone acetonide paste in the treatment of oral lichen planus
    Farzam Gorouhi
    Center for Research and Training in Skin Diseases and Leprosy, Medical Sciences University of Tehran, Tehran, Iran
    J Am Acad Dermatol 57:806-13. 2007
    ..1% to 4% of the general population. There is no published randomized active control clinical trial on pimecrolimus for the treatment of oral lichen planus (OLP)...

Research Grants30

  1. MECHANICAL STIMULATION OF IVD CELLS
    Lori A Setton; Fiscal Year: 2013
    ..will be performed as in Aim 1, and also compared against corresponding values for corticosteroid (triamcinolone acetonide) to test for therapeutic potential against the current standard-of-care...
  2. Bioequivalence of topical drug products: in vitro - in vivo correlations
    Audra L Stinchcomb; Fiscal Year: 2013
    ..A systematic examination of several key classes of topical drug products will be undertaken including, but not limited to lidocaine, triamcinolone acetonide, tretinoin, acyclovir and metronidazole.
  3. Vascular Remodeling and Effects of Angiogenic Inhibition
    Patricia Parsons Wingerter; Fiscal Year: 2006
    ..anti-VEGF inhibitors be deduced and quantified by region-based fractal analysis? Effects of the steriod triamcinolone acetonide will be quantified in the NPDR human retina and in another 2D, optically accessible tissue of similar ..
  4. Vacsular Remodeling and Effects of Angiogenic Inhibition in Diabetic Retinopathy
    Peter Kaiser; Fiscal Year: 2006
    ..anti-VEGF inhibitors be deduced and quantified by region-based fractal analysis? Effects of the steriod triamcinolone acetonide will be quantified in the NPDR human retina and in another 2D, optically accessible tissue of similar ..
  5. CHROMATIN-GLUCOCORTICOID INFLUENCES IN CLEFT PALATE
    ISAAC BEKHOR; Fiscal Year: 1980
    ..Our objectives include studies on the distribution of labeled triamcinolone acetonide in chromatin to look for the various binding sites for the labeled hormone both in active and inactive ..
  6. OCULAR MELANOMA
    Judy Kim; Fiscal Year: 2003
    ..Standardized clinical and data collection procedures will be employed, and standardized forms will be used in all centers. Central training and certification of all study staff will be required. ..
  7. ASTHMA CLINICAL RESEARCH NETWORK
    Elliot Israel; Fiscal Year: 2002
    ..Other studies will be considered if new information becomes available suggesting the need for additional trials. ..
  8. Apoptosis in Retinal Detachments
    David Zacks; Fiscal Year: 2006
    ..This will allow us to develop and test new neuroprotective therapies for improving visual outcomes in retinal disease. ..
  9. LUNG HEALTH STUDY--LONG TERM FOLLOW UP
    Donald Tashkin; Fiscal Year: 2002
    ..All ten of the original LHS clinical centers plan to participate in this study. To minimize bias, all surviving participants of the LHS will be invited to participate, giving a potential sample size of 5600. ..
  10. Micromass Quattro API TSQ For LC-MS/MS Quantitation
    Walter Hubbard; Fiscal Year: 2002
    ..phospholipids and products of phospholipid metabolism, fatty acid acyl conjugates of hydrocortisone and triamcinolone acetonide (TAA), neuropeptides, endogenous levels of hydrocortisone and cortisone in nasal and bronchoalveolar ..
  11. Project ASPIRE: Improving Pediatric Asthma Management for Urban Families
    Marianne Celano; Fiscal Year: 2007
    ..unreadable] [unreadable] [unreadable]..
  12. Treatment of Severe Persistent Asthma
    ROBERT LEMANSKE; Fiscal Year: 2007
    ..abstract_text> ..
  13. Informative Clinical Studies in Asthma
    Elliot Israel; Fiscal Year: 2007
    ..This latter analysis may permit us to individualize therapy and therefore maximize benefit, decrease toxicity, and decrease cost. ..
  14. CARE Network - Madison Clinical Center
    ROBERT LEMANSKE; Fiscal Year: 2008
    ..abstract_text> ..
  15. The Subproteome in Age-related Macular Degeneration
    Timothy Olsen; Fiscal Year: 2008
    ..This information will enable us to generate a rational approach to identify targeted therapies. ..
  16. CYTOKINE DYSREGULATION, VIRUSES, AND CHILDHOOD ASTHMA
    ROBERT LEMANSKE; Fiscal Year: 2001
    ..The results of these studies will provide information that will be a major step forward in our understanding of the relative influence that genetic and environmental risk factors on the development of childhood asthma. ..
  17. Role of Retinal Microvasculature in Posterior Uveitis
    Justine Smith; Fiscal Year: 2006
    ..The studies should also have implications for unrelated diseases affecting the retinal circulation, as well as tissue-specific inflammations and infections at other body sites. [unreadable] [unreadable]..
  18. High Purity Amphotericin B: A Safer Antimycotic in AIDS
    John Cleary; Fiscal Year: 2005
    ..abstract_text> ..
  19. FEMALE SEXUAL AROUSAL: CLITORAL AND VAGINAL PHYSIOLOGY
    Abdulmaged Traish; Fiscal Year: 2003
    ....
  20. SCLERODERMA LUNG STUDY
    Donald Tashkin; Fiscal Year: 2003
    ..abstract_text> ..
  21. Pharmacogenomics/natural products + antifungal activity
    John Cleary; Fiscal Year: 2004
    ..Probing this array with eukaryotic mRNA from cells exposed to novel antifungals would predict common mechanism of action and likelihood of toxicity, activity and resistance. ..
  22. Gene Delivery to the Trabecular Meshwork
    Douglas Rhee; Fiscal Year: 2004
    ..These studies would set the foundation for future evaluations of the function of MIF in the TM and MIF?s potential as a candidate for gene therapy for the treatment of glaucoma. ..
  23. Neglect, Adherence and Depression in Asthmatic Children
    Marianne Celano; Fiscal Year: 2005
    ..abstract_text> ..
  24. Endothelial Transmigration Across the RPE Barrier
    Mary Elizabeth Hartnett; Fiscal Year: 2005
    ..Increased knowledge of the mechanisms that cause this destructive phenomenon may lead to future means to prevent CNV in the neurosensory retina, and thus, reduce vision loss in AMD. ..
  25. RPE-Mphi Binding: Ca++_&O2-_Dependent AMD Responses
    Victor Elner; Fiscal Year: 2008
    ..This new knowledge is likely to lead to advances in therapy, which may stem or prevent AMD. ..
  26. COUNTER REGULATORY LIPID SIGNALS IN SEVERE ASTHMA
    Elliot Israel; Fiscal Year: 2005
    ..Such information may ultimately lead to new therapeutic strategies. ..
  27. Distal Lung Inflammation Effect on Asthma Exacerbations
    Donald Tashkin; Fiscal Year: 2008
    ..This study has the potential to clarify the contribution of the "silent zone" to the persistent morbidity encountered with asthma. ..
  28. ASTHMA CLINICAL RESEARCH NETWORK
    ROBERT LEMANSKE; Fiscal Year: 2002
    ....
  29. ROLE OF CONDITIONING IN THE PHARMACOTHERAPY OF PSORIASIS
    Robert Ader; Fiscal Year: 2004
    ....
  30. IMMUNE MECHANISMS OF MIDDLE EAR DISEASE
    David Skoner; Fiscal Year: 2006
    ..The primary hypothesis is that cytokine genotype is predictive of illness expression and of OM incidence during a documented RSV infection in young children. ..